Anastassia Amaro, M.D.
Associate Professor of Clinical Medicine (Endocrinology, Diabetes and Metabolism)
Attending Physician, Penn Rodebaugh Diabetes Center, The Hospital of the University of Pennsylvania
Medical Director, Penn Metabolic Medicine Clinic
Medical Director, Center for Weight and Eating Disorders
Department: Medicine
Contact information
Penn Metabolic Medicine
3737 Market St
Philadelphia, PA 19104
3737 Market St
Philadelphia, PA 19104
Office: 215-294-9525
Education:
MD (Summa Cum Laude)
Sechenov Moscow Medical Academy, Moscow, Russia, 1999.
Permanent linkMD (Summa Cum Laude)
Sechenov Moscow Medical Academy, Moscow, Russia, 1999.
Description of Clinical Expertise
Evaluation and medical treatment of patients with obesity and its complications. Novel therapies for treating obesity. Pre-and post-bariatric surgery care. Medical treatment of Diabetes Mellitus. Continuous glucose monitors. Continuous insulin infusion devices (insulin pumps). Hypoglycemia after bariatric surgery. Insulinoma.Description of Research Expertise
Diabetes and obesity clinical trials.Selected Publications
Thomas A Wadden, Ariana M Chao, Molly Moore, Jena S Tronieri, Adam Gilden, Anastassia Amaro, Sharon Leonard, John M Jakicic : The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Clinical Opportunities. Curr Obes Rep December 2023.Authors: Emily Gleason BA, Lindsay Levine BA, Iris T. Lee, MD, Nathanael Koelper, MPH, Anastassia Amaro, MD, Anuja Dokras, MD, MHCI, PhD: Effect of Glucagon-Like Peptide 1 Receptor Agonist Pharmacotherapy on Weight Loss in Patients with and Without Polycystic Ovary Syndrome. ASRM 2023 Scientific Congress October 2023.
R. Jones Jr, C. Maskart, J. Radway, A. Amaro, S. Cardillo: A Multimodal Curriculum to Improve Medical Student Gender-affirming Communication Skills, poster presentation. ENDO Society June 2023.
A. Rivadeneira Rodriguez, M. Walker, R. Gallop, A. Amaro: Single Center Retrospective Matched Cohort Study of glp1ra-Induced Weight Loss in Patients With Post-bariatric Weight Regain vs Non-surgical Controls, poster presentation. ENDO Society June 2023.
Amaro A, Skolnik NS, Sugimoto D.: Cardiometabolic risk factors efficacy of semaglutide in the STEP program. Postgrad Med 134(sup1): 18-27, January 2023.
Amaro A, Sugimoto D, Wharton S.: Efficacy and safety of semaglutide for weight management: evidence from the STEP program. Postgrad Med 134(Sup1): 5-17, January 2023.
Amaro A, Kaplan M, Massie DC. : Managed care considerations of weight management interventions for obesity. Am J Manag Care 28(15 suppl): 307-318, December 2022.
Walker MP, Shenoy V, Metz DC, Stanley CA, Fraker D, Chandrasekhara V, Amaro A.: Case presentation of 8-year follow up of recurrent malignant duodenal Insulinoma and lymph node metastases and literature review of malignant Insulinoma management. BMC Endocr Disord 22(1), December 2022.
Massie DC, Amaro A, Kaplan M. : Patient well-being and the clinical and economic burdens associated with obesity in the United States. Am J Manag Care 28(15 suppl): 279-287, December 2022.
Chao AM, Tronieri JS, Amaro A, Wadden TA.: Clinical Insight on Semaglutide for Chronic Weight Management in Adults: Patient Selection and Special Considerations. Drug Des Devel Ther 16: 4449-4461, December 2022.